Colorectal lesion and duodenal adenomatous lesion adenoma, cancer
Conditions
Interventions
ESD is performed using WLI in the WLI group and ACI in the ACI group.
Sponsors
Yamasaki Yasushi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: i) Patient with colorectal or duodenal adenomatous lesion considered difficult to resect en bloc by snare on endoscopic diagnosis. ii) 18 years of age or older iii) Patienst who have been fully informed consen t.
Exclusion criteria
Exclusion criteria: Colorectal ESD group i) Suspected of invasive cancer ii) Suspected of recurrence polyps iii) Inflammatory Bowel Disease (IBD) iv) Familial Adenomatous Polyposis (FAP) v) Patients who have difficulty with withdrawal of medication in accordance with antithrombotic dru g guideline vi) Patients on dialysis vii) Patients who judged as inappropriate candida te by the chief medical examine Duodenal ESD or LECS group i) Suspected of invasive cancer ii) Suspected of recurrence polyps iii) Lesions on the duodenal papilla iv) Patients who have difficulty with withdrawal of medication in accordance with antithrombotic dru g guideline v) Patients on dialysis vi) Patients who judged as inappropriate candida te by the chief medical examine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of events of intraoperative bleeding requiring endoscopic hemostasis and muscular injury. | — |
Secondary
| Measure | Time frame |
|---|---|
| i) Procedure time ii) Resection outcome and adverse events iii) Rate of patients treated with hemostatic forceps | — |
Contacts
Public ContactJunki Toyosawa
Okayama University Hospital
Outcome results
None listed